# FTXH holdings: all 50 positions

> All 50 FTXH holdings with weights, as of Oct 13, 2026. The top 3 are ABBV 7.85%, LLY 7.40% and PFE 7.32%. Download the full list as a CSV.

Data as of Oct 13, 2026. Rebuilt every trading night.

FTXH held 50 positions as of Oct 13, 2026. AbbVie Inc. is the largest at 7.85%; the top 10 are 55.0% of the fund.

Source: First Trust (https://www.ftportfolios.com/Retail/Etf/EtfHoldings.aspx?Ticker=FTXH).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | AbbVie Inc. | ABBV | 7.85% |
| 2 | Eli Lilly and Company | LLY | 7.40% |
| 3 | Pfizer Inc. | PFE | 7.32% |
| 4 | Merck & Co., Inc. | MRK | 7.05% |
| 5 | Johnson & Johnson | JNJ | 6.86% |
| 6 | Biogen Inc. | BIIB | 3.88% |
| 7 | Viatris Inc. | VTRS | 3.83% |
| 8 | Gilead Sciences, Inc. | GILD | 3.71% |
| 9 | Zoetis Inc. | ZTS | 3.54% |
| 10 | Amgen Inc. | AMGN | 3.52% |
| 11 | United Therapeutics Corporation | UTHR | 3.47% |
| 12 | Regeneron Pharmaceuticals, Inc. | REGN | 3.46% |
| 13 | Vertex Pharmaceuticals Incorporated | VRTX | 3.27% |
| 14 | Incyte Corporation | INCY | 3.20% |
| 15 | Bristol-Myers Squibb Company | BMY | 3.11% |
| 16 | Jazz Pharmaceuticals Plc | JAZZ | 2.45% |
| 17 | Exelixis, Inc. | EXEL | 2.43% |
| 18 | Illumina, Inc. | ILMN | 2.30% |
| 19 | Halozyme Therapeutics, Inc. | HALO | 1.62% |
| 20 | Medpace Holdings, Inc. | MEDP | 1.54% |
| 21 | Alnylam Pharmaceuticals, Inc. | ALNY | 1.18% |
| 22 | Elanco Animal Health Incorporated | ELAN | 1.18% |
| 23 | BioMarin Pharmaceutical Inc. | BMRN | 1.17% |
| 24 | Neurocrine Biosciences, Inc. | NBIX | 1.17% |
| 25 | Charles River Laboratories International, Inc. | CRL | 1.06% |
| | US Dollar | | 0.10% |
| | Cash and other net assets | | −0.02% |

The largest 25 of 50 positions are shown. All of them: https://etfiq.com/funds/ftxh/holdings/ftxh-holdings.csv (CSV) or https://etfiq.com/data/books/ftxh.json (JSON).

Fund page: https://etfiq.com/funds/ftxh

Cite: ETFIQ, Holdings of FTXH, data as of Oct 13, 2026. https://etfiq.com/funds/ftxh/holdings/